Food and Drug Administration grant notices posted in 2024, now closed
26 Food and Drug Administration grant notices posted on Grants.gov in 2024 that have closed, with their numbers and dates.
- RFA-FD-25-001: Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
- RFA-FD-24-042: Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U18) - Clinical Trails Not Allowed
- RFA-FD-24-017: Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U18) - Clinical Trials Not Allowed
- RFA-FD-24-040: Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trials Optional
- RFA-FD-24-041: Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional
- RFA-FD-24-036: Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, and Policy Development of Medical Products for Ongoing Public Health Activities, U01 Clinical Trial Not Allowed
- RFA-FD-24-035: Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical Trial Not Allowed
- RFA-FD-24-037: Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
- RFA-FD-24-016: Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade Development Facility (STDF) (U01) Clinical Trials Not Allowed
- RFA-FD-24-031: Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed
- RFA-FD-24-034: Alliance to Support the Activities of the Integrated Food Safety System (IFSS), including the Grade “A” Milk Safety and National Shellfish Sanitation Programs (U01) Clinical Trials Not Allowed
- RFA-FD-24-030: Drug Development Tools Research Grants (U01) Clinical Trials Optional
- RFA-FD-24-039: Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U19) Clinical Trials Not Allowed
- RFA-FD-24-032: Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
- RFA-FD-24-033: Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U19) Clinical Trials Not Allowed
- RFA-FD-24-038: Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional
- RFA-FD-24-025: Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
- RFA-FD-24-005: Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed
- RFA-FD-24-006: Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional
- RFA-FD-24-007: Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
- RFA-FD-24-008: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
- RFA-FD-24-009: Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
- RFA-FD-24-010: Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed
- RFA-FD-24-011: Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
- RFA-FD-24-027: Critical Path Public Private Partnerships Clinical Trials Optional
- RFA-FD-24-029: Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional